EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: a large U.S. experience over 6 years (with video)

Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of GFV. A retrospective chart review of patients treated fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastrointestinal endoscopy Jg. 83; H. 6; S. 1164 - 1172
Hauptverfasser: Bhat, Yasser M., Weilert, Frank, Fredrick, R. Todd, Kane, Steven D., Shah, Janak N., Hamerski, Chris M., Binmoeller, Kenneth F.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier Inc 01.06.2016
Schlagworte:
ISSN:0016-5107, 1097-6779, 1097-6779
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of GFV. A retrospective chart review of patients treated for GFV was performed. The main outcomes measured were hemostasis, obliteration on surveillance EUS, post-treatment bleeding rate, and adverse events. From March 2009 to 2015, 152 patients with GFV were treated. Seven (5%) had active hemorrhage, 105 (69%) had recent bleeding, and 40 (26%) were treated for primary prophylaxis. Treatment was technically successful in 151 patients (>99%). Mean number of coils was 1.4 (range, 1-4 coils), and mean volume of CYA was 2 mL (range, 0.5-6). Follow-up was available for 125 patients with treated GFV (mean, 436 days; range, 30-2043). Among 100 patients with follow-up EUS examinations, complete obliteration (on Doppler study) of GFV was confirmed in 93 (93%). Post-treatment bleeding from obliterated GFV occurred in 3 of 93 patients (3%). Twenty-five patients who had clinical and/or EGD follow-up had 3 post-treatment bleeding episodes after a median follow-up of 324 days (range, 41-486). Among the 40 patients treated for primary prophylaxis, 28 underwent follow-up EUS and 27 (96%) had confirmed obliteration. Mild postprocedure abdominal pain occurred in 4 of 125 patients (3%), and clinical signs of pulmonary embolization were seen in 1 patient (1%). Another 4 of 125 patients (3%) presented with minor delayed upper GI bleeding from coil/glue extrusion. EUS-guided combined coil and CYA glue injection of high-risk GFV appears to be highly effective for hemostasis in active bleeding and primary and secondary bleeding prophylaxis. Once obliteration was achieved, post-treatment bleeding from GFV occurred in only 3% during long-term follow-up. Combination therapy appears safe and may reduce the risk of CYA embolization.
AbstractList Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of GFV. A retrospective chart review of patients treated for GFV was performed. The main outcomes measured were hemostasis, obliteration on surveillance EUS, post-treatment bleeding rate, and adverse events. From March 2009 to 2015, 152 patients with GFV were treated. Seven (5%) had active hemorrhage, 105 (69%) had recent bleeding, and 40 (26%) were treated for primary prophylaxis. Treatment was technically successful in 151 patients (>99%). Mean number of coils was 1.4 (range, 1-4 coils), and mean volume of CYA was 2 mL (range, 0.5-6). Follow-up was available for 125 patients with treated GFV (mean, 436 days; range, 30-2043). Among 100 patients with follow-up EUS examinations, complete obliteration (on Doppler study) of GFV was confirmed in 93 (93%). Post-treatment bleeding from obliterated GFV occurred in 3 of 93 patients (3%). Twenty-five patients who had clinical and/or EGD follow-up had 3 post-treatment bleeding episodes after a median follow-up of 324 days (range, 41-486). Among the 40 patients treated for primary prophylaxis, 28 underwent follow-up EUS and 27 (96%) had confirmed obliteration. Mild postprocedure abdominal pain occurred in 4 of 125 patients (3%), and clinical signs of pulmonary embolization were seen in 1 patient (1%). Another 4 of 125 patients (3%) presented with minor delayed upper GI bleeding from coil/glue extrusion. EUS-guided combined coil and CYA glue injection of high-risk GFV appears to be highly effective for hemostasis in active bleeding and primary and secondary bleeding prophylaxis. Once obliteration was achieved, post-treatment bleeding from GFV occurred in only 3% during long-term follow-up. Combination therapy appears safe and may reduce the risk of CYA embolization.
Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of GFV.BACKGROUND AND AIMSConventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of GFV.A retrospective chart review of patients treated for GFV was performed. The main outcomes measured were hemostasis, obliteration on surveillance EUS, post-treatment bleeding rate, and adverse events.METHODSA retrospective chart review of patients treated for GFV was performed. The main outcomes measured were hemostasis, obliteration on surveillance EUS, post-treatment bleeding rate, and adverse events.From March 2009 to 2015, 152 patients with GFV were treated. Seven (5%) had active hemorrhage, 105 (69%) had recent bleeding, and 40 (26%) were treated for primary prophylaxis. Treatment was technically successful in 151 patients (>99%). Mean number of coils was 1.4 (range, 1-4 coils), and mean volume of CYA was 2 mL (range, 0.5-6). Follow-up was available for 125 patients with treated GFV (mean, 436 days; range, 30-2043). Among 100 patients with follow-up EUS examinations, complete obliteration (on Doppler study) of GFV was confirmed in 93 (93%). Post-treatment bleeding from obliterated GFV occurred in 3 of 93 patients (3%). Twenty-five patients who had clinical and/or EGD follow-up had 3 post-treatment bleeding episodes after a median follow-up of 324 days (range, 41-486). Among the 40 patients treated for primary prophylaxis, 28 underwent follow-up EUS and 27 (96%) had confirmed obliteration. Mild postprocedure abdominal pain occurred in 4 of 125 patients (3%), and clinical signs of pulmonary embolization were seen in 1 patient (1%). Another 4 of 125 patients (3%) presented with minor delayed upper GI bleeding from coil/glue extrusion.RESULTSFrom March 2009 to 2015, 152 patients with GFV were treated. Seven (5%) had active hemorrhage, 105 (69%) had recent bleeding, and 40 (26%) were treated for primary prophylaxis. Treatment was technically successful in 151 patients (>99%). Mean number of coils was 1.4 (range, 1-4 coils), and mean volume of CYA was 2 mL (range, 0.5-6). Follow-up was available for 125 patients with treated GFV (mean, 436 days; range, 30-2043). Among 100 patients with follow-up EUS examinations, complete obliteration (on Doppler study) of GFV was confirmed in 93 (93%). Post-treatment bleeding from obliterated GFV occurred in 3 of 93 patients (3%). Twenty-five patients who had clinical and/or EGD follow-up had 3 post-treatment bleeding episodes after a median follow-up of 324 days (range, 41-486). Among the 40 patients treated for primary prophylaxis, 28 underwent follow-up EUS and 27 (96%) had confirmed obliteration. Mild postprocedure abdominal pain occurred in 4 of 125 patients (3%), and clinical signs of pulmonary embolization were seen in 1 patient (1%). Another 4 of 125 patients (3%) presented with minor delayed upper GI bleeding from coil/glue extrusion.EUS-guided combined coil and CYA glue injection of high-risk GFV appears to be highly effective for hemostasis in active bleeding and primary and secondary bleeding prophylaxis. Once obliteration was achieved, post-treatment bleeding from GFV occurred in only 3% during long-term follow-up. Combination therapy appears safe and may reduce the risk of CYA embolization.CONCLUSIONSEUS-guided combined coil and CYA glue injection of high-risk GFV appears to be highly effective for hemostasis in active bleeding and primary and secondary bleeding prophylaxis. Once obliteration was achieved, post-treatment bleeding from GFV occurred in only 3% during long-term follow-up. Combination therapy appears safe and may reduce the risk of CYA embolization.
Background and Aims Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of GFV. Methods A retrospective chart review of patients treated for GFV was performed. The main outcomes measured were hemostasis, obliteration on surveillance EUS, post-treatment bleeding rate, and adverse events. Results From March 2009 to 2015, 152 patients with GFV were treated. Seven (5%) had active hemorrhage, 105 (69%) had recent bleeding, and 40 (26%) were treated for primary prophylaxis. Treatment was technically successful in 151 patients (>99%). Mean number of coils was 1.4 (range, 1-4 coils), and mean volume of CYA was 2 mL (range, 0.5-6). Follow-up was available for 125 patients with treated GFV (mean, 436 days; range, 30-2043). Among 100 patients with follow-up EUS examinations, complete obliteration (on Doppler study) of GFV was confirmed in 93 (93%). Post-treatment bleeding from obliterated GFV occurred in 3 of 93 patients (3%). Twenty-five patients who had clinical and/or EGD follow-up had 3 post-treatment bleeding episodes after a median follow-up of 324 days (range, 41-486). Among the 40 patients treated for primary prophylaxis, 28 underwent follow-up EUS and 27 (96%) had confirmed obliteration. Mild postprocedure abdominal pain occurred in 4 of 125 patients (3%), and clinical signs of pulmonary embolization were seen in 1 patient (1%). Another 4 of 125 patients (3%) presented with minor delayed upper GI bleeding from coil/glue extrusion. Conclusions EUS-guided combined coil and CYA glue injection of high-risk GFV appears to be highly effective for hemostasis in active bleeding and primary and secondary bleeding prophylaxis. Once obliteration was achieved, post-treatment bleeding from GFV occurred in only 3% during long-term follow-up. Combination therapy appears safe and may reduce the risk of CYA embolization.
Author Kane, Steven D.
Fredrick, R. Todd
Binmoeller, Kenneth F.
Shah, Janak N.
Bhat, Yasser M.
Weilert, Frank
Hamerski, Chris M.
Author_xml – sequence: 1
  givenname: Yasser M.
  surname: Bhat
  fullname: Bhat, Yasser M.
– sequence: 2
  givenname: Frank
  surname: Weilert
  fullname: Weilert, Frank
– sequence: 3
  givenname: R. Todd
  orcidid: 0000-0002-2153-3194
  surname: Fredrick
  fullname: Fredrick, R. Todd
– sequence: 4
  givenname: Steven D.
  surname: Kane
  fullname: Kane, Steven D.
– sequence: 5
  givenname: Janak N.
  surname: Shah
  fullname: Shah, Janak N.
– sequence: 6
  givenname: Chris M.
  surname: Hamerski
  fullname: Hamerski, Chris M.
– sequence: 7
  givenname: Kenneth F.
  surname: Binmoeller
  fullname: Binmoeller, Kenneth F.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26452992$$D View this record in MEDLINE/PubMed
BookMark eNqFkstuFDEQRVsoiDzgA9ggL8Oim7L7NQYJCUXhIUViMczaqrarBw899mB3D8yn8Le4M8kmEmFllXTPLeveOs9OnHeUZS85FBx482ZTrC0VAnhdgCyggifZGQfZ5k3bypPsDJIorzm0p9l5jBsAWIiSP8tORVPVQkpxlv25Xi3z9WQNGTYGwnFLbmS-Z2uMY7Ca9ZMzOLA9poEi-2XH70z7bWddIqzbkB6tdzOhvR0iQ2eYPqDzqMNhwJHYepjoLUM2YFgTWxXLgtHvHQVLThPzewqsYQfCENnlrf0-_ca_fp497XGI9OLuvchWH6-_XX3Ob75--nL14SbXNfAxL3mF1EGNFZHBhakIeoMdJyxFA10tRCnbDsGAMaavS0LJGzAdbzinRYvlRXZ59N0F_3OiOKqtjZqGAR35KSreSqgaIeoqSV_dSaduS0btgt1iOKj7OJOgPQp08DEG6pW2I84BjQHtoDiouTi1Uak4NRenQKpUXCL5A_Le_DHm3ZGhFM_eUlBR34ZqbEi1KOPto_T7B7QerLMahx90oLjxU3Apd8VVFArUcj6m-ZZ4DULWdZsM5L8N_rP8L0xR2c8
CitedBy_id crossref_primary_10_1007_s10396_021_01165_4
crossref_primary_10_1055_a_1214_6213
crossref_primary_10_1111_den_13674
crossref_primary_10_1159_000510132
crossref_primary_10_1089_lap_2021_0377
crossref_primary_10_4103_sjg_sjg_214_23
crossref_primary_10_1007_s10190_017_0612_3
crossref_primary_10_1002_jhbp_528
crossref_primary_10_1007_s10620_017_4671_2
crossref_primary_10_1097_MOG_0000000000001133
crossref_primary_10_1007_s11894_018_0637_6
crossref_primary_10_1016_j_jceh_2017_11_002
crossref_primary_10_1007_s10620_022_07425_8
crossref_primary_10_1111_den_14916
crossref_primary_10_1016_j_sempedsurg_2022_151190
crossref_primary_10_1007_s11901_023_00597_5
crossref_primary_10_1016_j_gie_2016_11_021
crossref_primary_10_1016_j_gie_2023_08_011
crossref_primary_10_1097_HC9_0000000000000767
crossref_primary_10_1097_MEG_0000000000001893
crossref_primary_10_1016_j_gie_2021_01_025
crossref_primary_10_1016_j_gie_2024_10_005
crossref_primary_10_1093_gastro_goae082
crossref_primary_10_1097_HEP_0000000000000647
crossref_primary_10_1016_j_gie_2024_01_044
crossref_primary_10_1007_s10620_017_4747_z
crossref_primary_10_1111_den_13661
crossref_primary_10_1177_2050640619854671
crossref_primary_10_3892_etm_2019_7923
crossref_primary_10_4254_wjh_v13_i8_887
crossref_primary_10_1111_den_13305
crossref_primary_10_1016_j_giec_2017_06_011
crossref_primary_10_1097_MOG_0000000000000294
crossref_primary_10_4253_wjge_v13_i8_296
crossref_primary_10_4253_wjge_v16_i12_640
crossref_primary_10_1111_den_13666
crossref_primary_10_1016_j_tgie_2017_08_004
crossref_primary_10_1097_SLE_0000000000001355
crossref_primary_10_4103_EUS_D_21_00177
crossref_primary_10_1177_17562848221101712
crossref_primary_10_3390_medicina60010116
crossref_primary_10_1016_j_bpg_2016_10_010
crossref_primary_10_1016_j_gie_2024_06_038
crossref_primary_10_1016_j_rgmxen_2018_03_005
crossref_primary_10_1007_s12328_022_01600_0
crossref_primary_10_1002_lt_26383
crossref_primary_10_1097_MOG_0000000000000581
crossref_primary_10_1016_j_cgh_2016_05_020
crossref_primary_10_1016_j_jchirv_2023_07_005
crossref_primary_10_1055_s_0042_1745861
crossref_primary_10_1016_j_cgh_2023_03_027
crossref_primary_10_1055_s_0042_1745864
crossref_primary_10_14309_crj_0000000000000072
crossref_primary_10_1007_s12328_020_01259_5
crossref_primary_10_1111_liv_15181
crossref_primary_10_12998_wjcc_v10_i4_1447
crossref_primary_10_1016_j_gie_2021_09_009
crossref_primary_10_1097_eus_0000000000000038
crossref_primary_10_1016_j_gie_2016_10_005
crossref_primary_10_1016_j_gie_2017_08_015
crossref_primary_10_1159_000529089
crossref_primary_10_1016_j_ajg_2022_04_004
crossref_primary_10_3390_diagnostics13061031
crossref_primary_10_1097_MCG_0000000000002143
crossref_primary_10_1016_j_tgie_2017_10_008
crossref_primary_10_1016_j_cgh_2019_09_048
crossref_primary_10_1089_lap_2022_0416
crossref_primary_10_1053_j_gastro_2018_02_023
crossref_primary_10_1016_j_jaccas_2021_11_008
crossref_primary_10_1055_s_0043_1771305
crossref_primary_10_1055_a_1158_8488
crossref_primary_10_1055_s_0038_1656511
crossref_primary_10_1016_j_gie_2023_07_043
crossref_primary_10_1055_s_0043_1771307
crossref_primary_10_3390_jcm12062165
crossref_primary_10_1186_s11671_018_2698_8
crossref_primary_10_1097_MD_0000000000043499
crossref_primary_10_1177_2631774519878282
crossref_primary_10_1016_j_bpg_2022_101816
crossref_primary_10_1177_2050640618792817
crossref_primary_10_1055_a_1814_4140
crossref_primary_10_4103_EUS_D_21_00260
crossref_primary_10_4253_wjge_v13_i1_13
crossref_primary_10_3748_wjg_v30_i7_742
crossref_primary_10_1016_j_ultrasmedbio_2020_02_011
crossref_primary_10_1002_hep4_1289
crossref_primary_10_4103_ejim_ejim_57_19
crossref_primary_10_1007_s11894_020_00801_2
crossref_primary_10_1155_2021_9948979
crossref_primary_10_1093_gastro_goaa082
crossref_primary_10_3748_wjg_v31_i24_108508
crossref_primary_10_1016_j_tgie_2017_03_006
crossref_primary_10_3390_jcm8111786
crossref_primary_10_3390_diagnostics15080967
crossref_primary_10_1016_j_gie_2015_12_015
crossref_primary_10_4103_EUS_D_22_00006
crossref_primary_10_1007_s11901_018_0415_9
crossref_primary_10_1007_s11605_020_04674_8
crossref_primary_10_1111_den_14713
crossref_primary_10_1186_s12876_020_01513_7
crossref_primary_10_14309_ctg_0000000000000175
crossref_primary_10_1136_bcr_2017_219615
crossref_primary_10_1007_s00464_018_6462_z
crossref_primary_10_1016_j_cld_2024_12_005
crossref_primary_10_1097_MOG_0000000000001072
crossref_primary_10_1002_hep_28906
crossref_primary_10_1016_j_tige_2021_09_006
crossref_primary_10_1016_j_cgh_2020_09_029
crossref_primary_10_1097_MEG_0000000000001200
crossref_primary_10_4254_wjh_v13_i11_1459
crossref_primary_10_1016_j_cld_2019_07_005
crossref_primary_10_1016_j_tige_2021_01_001
crossref_primary_10_1007_s12664_024_01681_4
crossref_primary_10_1016_j_jviscsurg_2023_11_005
crossref_primary_10_37349_edd_2025_100576
crossref_primary_10_1093_gastro_goae026
crossref_primary_10_12998_wjcc_v10_i18_6254
crossref_primary_10_1016_j_jceh_2021_08_030
crossref_primary_10_1186_s12876_020_01333_9
crossref_primary_10_1016_j_cld_2020_04_011
crossref_primary_10_1016_j_gie_2021_06_029
crossref_primary_10_1053_j_gastro_2021_12_277
crossref_primary_10_1055_a_2644_4314
crossref_primary_10_1016_j_dld_2024_08_041
crossref_primary_10_14309_ajg_0000000000002487
crossref_primary_10_5937_afmnai42_50166
crossref_primary_10_1016_j_cld_2021_10_001
crossref_primary_10_1177_0300060519830207
crossref_primary_10_3390_diagnostics11112021
crossref_primary_10_4254_wjh_v13_i8_868
crossref_primary_10_4253_wjge_v15_i4_216
crossref_primary_10_1111_den_14770
crossref_primary_10_4103_EUS_D_22_00027
crossref_primary_10_1016_j_giec_2018_12_006
crossref_primary_10_1111_den_12872
crossref_primary_10_4292_wjgpt_v10_i1_1
crossref_primary_10_1007_s12664_018_0844_y
crossref_primary_10_1055_a_1243_0569
crossref_primary_10_4253_wjge_v14_i12_748
crossref_primary_10_7759_cureus_18955
crossref_primary_10_4103_EUS_D_21_00157
crossref_primary_10_1016_j_cgh_2021_01_027
crossref_primary_10_1097_MEG_0000000000002079
crossref_primary_10_1097_MOG_0000000000000839
crossref_primary_10_1111_jgh_15168
Cites_doi 10.1002/hep.21145
10.4253/wjge.v6.i6.254
10.1016/j.gie.2011.06.030
10.1016/j.gie.2008.02.050
10.1016/j.gie.2007.03.008
10.1016/S0016-5107(05)80599-1
10.1016/j.gie.2013.05.009
10.3109/00365521.2014.929171
10.3748/wjg.v19.i37.6131
10.1016/j.jhep.2010.09.031
10.1002/hep.1840160607
10.2214/AJR.08.1610
10.1016/S1089-3261(05)70186-0
10.1016/S0016-5107(97)70202-5
10.1016/S0016-5107(03)02865-7
10.1016/j.gie.2013.04.166
10.1002/hep.510300523
10.3748/wjg.v20.i39.14495
10.1002/hep.510250209
10.1016/j.cgh.2010.05.019
10.1002/hep.21907
10.1016/j.jhep.2010.06.004
ContentType Journal Article
Copyright 2016 American Society for Gastrointestinal Endoscopy
American Society for Gastrointestinal Endoscopy
Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2016 American Society for Gastrointestinal Endoscopy
– notice: American Society for Gastrointestinal Endoscopy
– notice: Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.gie.2015.09.040
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6779
EndPage 1172
ExternalDocumentID 26452992
10_1016_j_gie_2015_09_040
S0016510715029557
1_s2_0_S0016510715029557
Genre Video-Audio Media
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FD8
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LZ1
M28
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OC.
ON0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
T5K
UNMZH
UV1
WH7
WOW
X7M
Z5R
ZGI
ZXP
~G-
~HD
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
LCYCR
9DU
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c501t-314aeb05a4eeda8d4e0fdab1ea3260b522397ba0d0dddf53ea9160db1611e87a3
ISICitedReferencesCount 160
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000376181700014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0016-5107
1097-6779
IngestDate Sun Sep 28 08:16:21 EDT 2025
Wed Feb 19 02:42:44 EST 2025
Tue Nov 18 21:52:31 EST 2025
Sat Nov 29 07:31:41 EST 2025
Fri Feb 23 02:27:24 EST 2024
Tue Feb 25 20:00:14 EST 2025
Tue Oct 14 19:34:47 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords GFV
CYA
TIPS
gastric fundal varices
transjugular intrahepatic portosystemic shunt
cyanoacrylate
Language English
License Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c501t-314aeb05a4eeda8d4e0fdab1ea3260b522397ba0d0dddf53ea9160db1611e87a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-2153-3194
OpenAccessLink http://www.giejournal.org/article/S0016510715029557/pdf
PMID 26452992
PQID 1790462254
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1790462254
pubmed_primary_26452992
crossref_citationtrail_10_1016_j_gie_2015_09_040
crossref_primary_10_1016_j_gie_2015_09_040
elsevier_sciencedirect_doi_10_1016_j_gie_2015_09_040
elsevier_clinicalkeyesjournals_1_s2_0_S0016510715029557
elsevier_clinicalkey_doi_10_1016_j_gie_2015_09_040
PublicationCentury 2000
PublicationDate 2016-06-01
PublicationDateYYYYMMDD 2016-06-01
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Gastrointestinal endoscopy
PublicationTitleAlternate Gastrointest Endosc
PublicationYear 2016
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Binmoeller, Weilert, Shah (bib11) 2011; 74
Romero-Castro, Ellrichmann, Ortiz-Moyano (bib15) 2013; 78
Loffroy, Estivalet, Cherblanc (bib18) 2013; 19
Romero-Castro, Pellicer-Bautista, Jimenez-Saenz (bib6) 2007; 66
Rengstorff, Binmoeller (bib14) 2004; 59
Iwase, Suga, Morise (bib8) 1995; 41
Gianotti, Charles, Hymes (bib19) 2014; 20
Gubler, Bauerfeind (bib7) 2014; 49
Franco, Gomes, Nakao (bib25) 2014; 6
Bhat, Banerjee, Barth (bib3) 2013; 78
Seewald, Leong, Imazu (bib9) 2008; 68
Sarin, Kumar (bib13) 1989; 84
Cheng, Wang, Li (bib20) 2010; 8
Sarin (bib5) 1997; 46
Fujii-Lau, Law, Wong Kee Song (bib16) 2015 Jul 3
Sarin, Lahoti, Saxena (bib21) 1992; 16
Kim, Shijo, Kokawa (bib12) 1997; 25
Garcia-Tsao, Sanyal, Grace (bib1) 2007; 46
D'Amico, de Franchis (bib23) 1999; 117
Barange, Peron, Imani (bib17) 1999; 30
Tan, Hou, Lin (bib4) 2006; 43
de Franchis, Baveno (bib2) 2010; 53
Rose (bib10) 2009; 192
Mishra, Sharma, Kumar (bib24) 2011; 54
de Franchis, Primignani (bib22) 2001; 5
Tan (10.1016/j.gie.2015.09.040_bib4) 2006; 43
Bhat (10.1016/j.gie.2015.09.040_bib3) 2013; 78
Barange (10.1016/j.gie.2015.09.040_bib17) 1999; 30
Loffroy (10.1016/j.gie.2015.09.040_bib18) 2013; 19
Cheng (10.1016/j.gie.2015.09.040_bib20) 2010; 8
Fujii-Lau (10.1016/j.gie.2015.09.040_bib16) 2015
Sarin (10.1016/j.gie.2015.09.040_bib21) 1992; 16
Mishra (10.1016/j.gie.2015.09.040_bib24) 2011; 54
Romero-Castro (10.1016/j.gie.2015.09.040_bib15) 2013; 78
Seewald (10.1016/j.gie.2015.09.040_bib9) 2008; 68
Rengstorff (10.1016/j.gie.2015.09.040_bib14) 2004; 59
Gianotti (10.1016/j.gie.2015.09.040_bib19) 2014; 20
Franco (10.1016/j.gie.2015.09.040_bib25) 2014; 6
Romero-Castro (10.1016/j.gie.2015.09.040_bib6) 2007; 66
D'Amico (10.1016/j.gie.2015.09.040_bib23) 1999; 117
Binmoeller (10.1016/j.gie.2015.09.040_bib11) 2011; 74
Garcia-Tsao (10.1016/j.gie.2015.09.040_bib1) 2007; 46
de Franchis (10.1016/j.gie.2015.09.040_bib2) 2010; 53
Iwase (10.1016/j.gie.2015.09.040_bib8) 1995; 41
Rose (10.1016/j.gie.2015.09.040_bib10) 2009; 192
Gubler (10.1016/j.gie.2015.09.040_bib7) 2014; 49
Kim (10.1016/j.gie.2015.09.040_bib12) 1997; 25
de Franchis (10.1016/j.gie.2015.09.040_bib22) 2001; 5
Sarin (10.1016/j.gie.2015.09.040_bib5) 1997; 46
Sarin (10.1016/j.gie.2015.09.040_bib13) 1989; 84
27206585 - Gastrointest Endosc. 2016 Jun;83(6):1173-5
References_xml – volume: 43
  start-page: 690
  year: 2006
  end-page: 697
  ident: bib4
  article-title: A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation
  publication-title: Hepatology
– volume: 25
  start-page: 307
  year: 1997
  end-page: 312
  ident: bib12
  article-title: Risk factors for hemorrhage from gastric fundal varices
  publication-title: Hepatology
– volume: 6
  start-page: 254
  year: 2014
  end-page: 259
  ident: bib25
  article-title: Efficacy and safety of endoscopic prophylactic treatment with undiluted cyanoacrylate for gastric varices
  publication-title: World J Gastrointest Endosc
– volume: 117
  start-page: A1199
  year: 1999
  ident: bib23
  article-title: End-of-the-century reappraisal of 6-week outcome of upper gastrointestinal bleeding in cirrhosis. A prospective study
  publication-title: Gastroenterology
– volume: 53
  start-page: 762
  year: 2010
  end-page: 768
  ident: bib2
  article-title: Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
  publication-title: J Hepatol
– year: 2015 Jul 3
  ident: bib16
  article-title: Endoscopic ultrasound (EUS)-guided coil injection therapy of esophagogastric and ectopic varices
  publication-title: Surg Endosc Epub
– volume: 84
  start-page: 1244
  year: 1989
  end-page: 1249
  ident: bib13
  article-title: Gastric varices: profile, classification, and management
  publication-title: Am J Gastrenterol
– volume: 20
  start-page: 14495
  year: 2014
  end-page: 14499
  ident: bib19
  article-title: Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder
  publication-title: World J Gastroenterol
– volume: 68
  start-page: 447
  year: 2008
  end-page: 454
  ident: bib9
  article-title: A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices
  publication-title: Gastointest Endosc
– volume: 59
  start-page: 553
  year: 2004
  end-page: 558
  ident: bib14
  article-title: A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans
  publication-title: Gastointest Endosc
– volume: 78
  start-page: 711
  year: 2013
  end-page: 721
  ident: bib15
  article-title: EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study
  publication-title: Gastrointest Endosc
– volume: 54
  start-page: 1161
  year: 2011
  end-page: 1167
  ident: bib24
  article-title: Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial
  publication-title: J Hepatol
– volume: 41
  start-page: 150
  year: 1995
  end-page: 154
  ident: bib8
  article-title: Color Doppler endoscopic ultrasonography for the evaluation of gastric varices and endoscopic obliteration with cyanoacrylate glue
  publication-title: Gastointest Endosc
– volume: 8
  start-page: 760
  year: 2010
  end-page: 766
  ident: bib20
  article-title: Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate
  publication-title: Clin Gastroenterol Hepatol
– volume: 78
  start-page: 209
  year: 2013
  end-page: 215
  ident: bib3
  article-title: Tissue adhesives: cyanoacrylate glue and fibrin sealant
  publication-title: Gastrointest Endosc
– volume: 46
  start-page: 922
  year: 2007
  end-page: 938
  ident: bib1
  article-title: Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
  publication-title: Hepatology
– volume: 16
  start-page: 1343
  year: 1992
  end-page: 1349
  ident: bib21
  article-title: Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients
  publication-title: Hepatology
– volume: 5
  start-page: 645
  year: 2001
  end-page: 663
  ident: bib22
  article-title: Natural history of portal hypertension in patients with cirrhosis
  publication-title: Clin Liver Dis
– volume: 192
  start-page: 321
  year: 2009
  end-page: 324
  ident: bib10
  article-title: Mechanical devices for arterial occlusion and therapeutic vascular occlusion utilizing steel coil technique: clinical applications
  publication-title: AJR Am J Roentgenol
– volume: 30
  start-page: 1139
  year: 1999
  end-page: 1143
  ident: bib17
  article-title: Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices
  publication-title: Hepatology
– volume: 66
  start-page: 402
  year: 2007
  end-page: 407
  ident: bib6
  article-title: EUS-guided injection of cyanoacrylate in perforating feeding veins in gastric varices: results in 5 cases
  publication-title: Gastointest Endosc
– volume: 74
  start-page: 1019
  year: 2011
  end-page: 1025
  ident: bib11
  article-title: EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection
  publication-title: Gastrointest Endosc
– volume: 19
  start-page: 6131
  year: 2013
  end-page: 6143
  ident: bib18
  article-title: Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage
  publication-title: World J Gastroenterol
– volume: 46
  start-page: 8
  year: 1997
  end-page: 14
  ident: bib5
  article-title: Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience
  publication-title: Gastrointest Endosc
– volume: 49
  start-page: 1136
  year: 2014
  end-page: 1142
  ident: bib7
  article-title: Safe and successful endoscopic initial treatment and long-term eradication of gastric varices by endoscopic ultrasound-guided histoacryl (N-butyl-2-cyanoacrylate) injection
  publication-title: Scand J Gastroenterol
– volume: 43
  start-page: 690
  year: 2006
  ident: 10.1016/j.gie.2015.09.040_bib4
  article-title: A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation
  publication-title: Hepatology
  doi: 10.1002/hep.21145
– volume: 84
  start-page: 1244
  year: 1989
  ident: 10.1016/j.gie.2015.09.040_bib13
  article-title: Gastric varices: profile, classification, and management
  publication-title: Am J Gastrenterol
– volume: 6
  start-page: 254
  year: 2014
  ident: 10.1016/j.gie.2015.09.040_bib25
  article-title: Efficacy and safety of endoscopic prophylactic treatment with undiluted cyanoacrylate for gastric varices
  publication-title: World J Gastrointest Endosc
  doi: 10.4253/wjge.v6.i6.254
– volume: 74
  start-page: 1019
  year: 2011
  ident: 10.1016/j.gie.2015.09.040_bib11
  article-title: EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection
  publication-title: Gastrointest Endosc
  doi: 10.1016/j.gie.2011.06.030
– volume: 68
  start-page: 447
  year: 2008
  ident: 10.1016/j.gie.2015.09.040_bib9
  article-title: A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices
  publication-title: Gastointest Endosc
  doi: 10.1016/j.gie.2008.02.050
– volume: 66
  start-page: 402
  year: 2007
  ident: 10.1016/j.gie.2015.09.040_bib6
  article-title: EUS-guided injection of cyanoacrylate in perforating feeding veins in gastric varices: results in 5 cases
  publication-title: Gastointest Endosc
  doi: 10.1016/j.gie.2007.03.008
– volume: 41
  start-page: 150
  year: 1995
  ident: 10.1016/j.gie.2015.09.040_bib8
  article-title: Color Doppler endoscopic ultrasonography for the evaluation of gastric varices and endoscopic obliteration with cyanoacrylate glue
  publication-title: Gastointest Endosc
  doi: 10.1016/S0016-5107(05)80599-1
– volume: 78
  start-page: 711
  year: 2013
  ident: 10.1016/j.gie.2015.09.040_bib15
  article-title: EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study
  publication-title: Gastrointest Endosc
  doi: 10.1016/j.gie.2013.05.009
– volume: 49
  start-page: 1136
  year: 2014
  ident: 10.1016/j.gie.2015.09.040_bib7
  article-title: Safe and successful endoscopic initial treatment and long-term eradication of gastric varices by endoscopic ultrasound-guided histoacryl (N-butyl-2-cyanoacrylate) injection
  publication-title: Scand J Gastroenterol
  doi: 10.3109/00365521.2014.929171
– volume: 19
  start-page: 6131
  year: 2013
  ident: 10.1016/j.gie.2015.09.040_bib18
  article-title: Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v19.i37.6131
– volume: 54
  start-page: 1161
  year: 2011
  ident: 10.1016/j.gie.2015.09.040_bib24
  article-title: Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.09.031
– volume: 16
  start-page: 1343
  year: 1992
  ident: 10.1016/j.gie.2015.09.040_bib21
  article-title: Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients
  publication-title: Hepatology
  doi: 10.1002/hep.1840160607
– volume: 192
  start-page: 321
  year: 2009
  ident: 10.1016/j.gie.2015.09.040_bib10
  article-title: Mechanical devices for arterial occlusion and therapeutic vascular occlusion utilizing steel coil technique: clinical applications
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.08.1610
– volume: 5
  start-page: 645
  year: 2001
  ident: 10.1016/j.gie.2015.09.040_bib22
  article-title: Natural history of portal hypertension in patients with cirrhosis
  publication-title: Clin Liver Dis
  doi: 10.1016/S1089-3261(05)70186-0
– volume: 117
  start-page: A1199
  year: 1999
  ident: 10.1016/j.gie.2015.09.040_bib23
  article-title: End-of-the-century reappraisal of 6-week outcome of upper gastrointestinal bleeding in cirrhosis. A prospective study
  publication-title: Gastroenterology
– volume: 46
  start-page: 8
  year: 1997
  ident: 10.1016/j.gie.2015.09.040_bib5
  article-title: Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience
  publication-title: Gastrointest Endosc
  doi: 10.1016/S0016-5107(97)70202-5
– volume: 59
  start-page: 553
  year: 2004
  ident: 10.1016/j.gie.2015.09.040_bib14
  article-title: A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans
  publication-title: Gastointest Endosc
  doi: 10.1016/S0016-5107(03)02865-7
– volume: 78
  start-page: 209
  year: 2013
  ident: 10.1016/j.gie.2015.09.040_bib3
  article-title: Tissue adhesives: cyanoacrylate glue and fibrin sealant
  publication-title: Gastrointest Endosc
  doi: 10.1016/j.gie.2013.04.166
– volume: 30
  start-page: 1139
  year: 1999
  ident: 10.1016/j.gie.2015.09.040_bib17
  article-title: Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices
  publication-title: Hepatology
  doi: 10.1002/hep.510300523
– volume: 20
  start-page: 14495
  year: 2014
  ident: 10.1016/j.gie.2015.09.040_bib19
  article-title: Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i39.14495
– volume: 25
  start-page: 307
  year: 1997
  ident: 10.1016/j.gie.2015.09.040_bib12
  article-title: Risk factors for hemorrhage from gastric fundal varices
  publication-title: Hepatology
  doi: 10.1002/hep.510250209
– volume: 8
  start-page: 760
  year: 2010
  ident: 10.1016/j.gie.2015.09.040_bib20
  article-title: Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2010.05.019
– volume: 46
  start-page: 922
  year: 2007
  ident: 10.1016/j.gie.2015.09.040_bib1
  article-title: Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
  publication-title: Hepatology
  doi: 10.1002/hep.21907
– volume: 53
  start-page: 762
  year: 2010
  ident: 10.1016/j.gie.2015.09.040_bib2
  article-title: Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.06.004
– year: 2015
  ident: 10.1016/j.gie.2015.09.040_bib16
  article-title: Endoscopic ultrasound (EUS)-guided coil injection therapy of esophagogastric and ectopic varices
  publication-title: Surg Endosc Epub
– reference: 27206585 - Gastrointest Endosc. 2016 Jun;83(6):1173-5
SSID ssj0008231
Score 2.560682
Snippet Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and rebleeding. We evaluated...
Background and Aims Conventional endoscopic treatment of gastric fundal varices (GFV) with cyanoacrylate (CYA) glue may be complicated by embolization and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1164
SubjectTerms Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Cyanoacrylates - therapeutic use
Embolization, Therapeutic - methods
Endosonography
Esophageal and Gastric Varices - therapy
Female
Gastric Fundus
Gastroenterology and Hepatology
Gastrointestinal Hemorrhage - prevention & control
Gastrointestinal Hemorrhage - therapy
Gastroscopy - methods
Hemostasis, Endoscopic
Humans
Male
Middle Aged
Retrospective Studies
Surgery, Computer-Assisted
Surgical Equipment
Tissue Adhesives - therapeutic use
Treatment Outcome
Young Adult
Title EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: a large U.S. experience over 6 years (with video)
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0016510715029557
https://www.clinicalkey.es/playcontent/1-s2.0-S0016510715029557
https://dx.doi.org/10.1016/j.gie.2015.09.040
https://www.ncbi.nlm.nih.gov/pubmed/26452992
https://www.proquest.com/docview/1790462254
Volume 83
WOSCitedRecordID wos000376181700014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1097-6779
  dateEnd: 20200430
  omitProxy: false
  ssIdentifier: ssj0008231
  issn: 0016-5107
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLZmQYgLYqcsIyNxAKpUWeuE2wgNm2CEmKnozXJit7TKJFU3TX8KP4d_xntekmFgBjhwiaqktlu_L8_fs99CyNMUluwiDYXnR4x5cVyEXp6pCAQiFZMsT8NcBwp_YIeH6XCYfdra-u5iYdYlq6r09DSb_VdRwz0QNobO_oO4m07hBnwGocMVxA7XvxL8weDIG68mEphk60UOlHAssERH0R1h7EfZXQtMJ7RwvucnYCErzMM0VYUjkUU9KU0K52IjqloU800J1LQ7LlfKBEmX6EfeHfSOerZUgNYT6BXa7Xc3MLN6T1cPgfF-tdt3sGz4Df6kGjNWgKJBWqwqWWOcTBtl8VWYVUKg20C7dftFgTYz0Ua67HwDw7mSc1sc_jP6CMlmRbFOvaaMm3V0ttsdQb91y-opo6L9jHl9ZkrQOB1uiuFYrJ5VyEFgkqT_slKYTYtpbzzBZKlBorPdmsxRZ0AyO9EoCfH4NzNF-86l53aPtsluyJIMFOvu_ruD4fuGDuA5qztO146F50bEdNS2j4u40UW2j-ZAxzfIdWu80H0DuptkS1W3yNWP1j3jNvnWYo822KP1iFrsUYM9arFHERjUYY822MMWGnsUsEd_wh5F7L2kgmrkUUQebZFHEXm0TzXy6DPdvcbd8ztk8Prg-NVbz9b-8IrED5ZADWKhcj8RMZA4kcpY-SMp8kAJsDf8HKwGINK58KUvpRwlkRJg5_gyBwMmUCkT0V2yU9WVuk9oXzAZpZHICyFhnvs5dMoiVQQhC0dxnHeI72adFzYxPtZnKbnzgJxykBlHmXE_4yCzDnnRNJmZrDCXfTl0ouQu3BkWaA5IvKwR-10jtbCaZsEDvgi5z4_QaIOFlYFlF2ZJwjokblpaFm3Y8Z8GfOJQxmGFwWNDeC_rFQzEMoxgD5O4Q-4Z-DV_2iH3wYVPHpJr7Wv8iOws5yv1mFwp1svJYr5Httkw3bOvzA-F1_j-
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EUS-guided+treatment+of+gastric+fundal+varices+with+combined+injection+of+coils+and+cyanoacrylate+glue%3A+a+large+U.S.+experience+over+6+years+%28with+video%29&rft.jtitle=Gastrointestinal+endoscopy&rft.au=Bhat%2C+Yasser+M&rft.au=Weilert%2C+Frank&rft.au=Fredrick%2C+R+Todd&rft.au=Kane%2C+Steven+D&rft.date=2016-06-01&rft.eissn=1097-6779&rft.volume=83&rft.issue=6&rft.spage=1164&rft_id=info:doi/10.1016%2Fj.gie.2015.09.040&rft_id=info%3Apmid%2F26452992&rft.externalDocID=26452992
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00165107%2FS0016510716X00053%2Fcov150h.gif